Chemoprevention of bladder cancer

[1]  M. Zeegers,et al.  Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk. , 2007, Cancer letters.

[2]  Liangdao Cheng,et al.  [Papillary urothelial neoplasms of low malignant potential]. , 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[3]  N. Malats,et al.  Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Vickers,et al.  Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer , 2006, BJU international.

[5]  Nurulain T Zaveri,et al.  Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. , 2006, Life sciences.

[6]  J. Leppert,et al.  Prevention of bladder cancer: a review. , 2006, European urology.

[7]  A. Sabichi,et al.  Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. , 2006, Oncology reports.

[8]  E. Messing,et al.  Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer. , 2005, The Journal of urology.

[9]  A. Yosry.  Schistosomiasis and neoplasia. , 2006, Contributions to microbiology.

[10]  J. Landman,et al.  Comparison of optical resolution with digital and standard fiberoptic cystoscopes in an in vitro model. , 2006, Urology.

[11]  H. Herr.  Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. , 2005, The Journal of urology.

[12]  Dietmar Schnorr,et al.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. , 2005, The Journal of urology.

[13]  E. Spitznagel,et al.  Meta‐analysis of soy food and risk of prostate cancer in men , 2005, International journal of cancer.

[14]  K. Wróblewski.  [Can the administration of large doses of vitamin C have a harmful effect?]. , 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[15]  D. Brenner,et al.  Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum. , 2005, Gastroenterology.

[16]  S. Lerner.  Bladder cancer clinical trials. , 2005, Urologic oncology.

[17]  Chun-Yuh Yang,et al.  Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. , 2005, Environmental research.

[18]  A. Sabichi,et al.  913: Results of a Randomized Chemoprevention Trial with Fenretinide in Non-Muscle Invasive Bladder Cancer , 2005 .

[19]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[20]  Marc A Pfeffer,et al.  Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention , 2005, The New England journal of medicine.

[21]  P. Ganz,et al.  The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. , 2005, Journal of the National Cancer Institute.

[22]  J. Rao,et al.  Green Tea Extract Modulates Actin Remodeling via Rho Activity in an In vitro Multistep Carcinogenic Model , 2005, Clinical Cancer Research.

[23]  Roberto Pastor-Barriuso,et al.  Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.

[24]  C. Knüsli,et al.  Phenacetin abuse and malignant tumors , 1982, Klinische Wochenschrift.

[25]  E. Szabo,et al.  How should we move the field of chemopreventive agent development forward in a productive manner? , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[26]  M. Liebman,et al.  Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  M. Stampfer,et al.  Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. , 2004, Journal of the American Society of Nephrology : JASN.

[28]  Jian-Min Yuan,et al.  Dietary soy and increased risk of bladder cancer: A prospective cohort study of men in Shanghai, China , 2004, International journal of cancer.

[29]  R. Sylvester,et al.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, The Journal of urology.

[30]  P. Grandjean,et al.  Extended follow-up of cancer incidence in fluoride-exposed workers. , 2004, Journal of the National Cancer Institute.

[31]  E. Messing,et al.  Gender, racial and age differences in bladder cancer incidence and mortality. , 2004, Urologic oncology.

[32]  D. Lamm,et al.  Antitumor activity of common antibiotics against superficial bladder cancer. , 2004, Urology.

[33]  N. Pratt,et al.  Update of a prospective study of mortality and cancer incidence in the Australian petroleum industry , 2004, Occupational and Environmental Medicine.

[34]  J. Chang-Claude,et al.  Occupation and bladder cancer among men in Western Europe , 2003, Cancer Causes & Control.

[35]  P. Sulem,et al.  Cancer incidence among marine engineers, a population-based study (Iceland) , 2003, Cancer Causes and Control.

[36]  J. Chang-Claude,et al.  The contribution of cigarette smoking to bladder cancer in women (pooled European data) , 2001, Cancer Causes & Control.

[37]  R. Hayes,et al.  Are the known bladder cancer risk-factors associated with more advanced bladder cancer? , 1993, Cancer Causes & Control.

[38]  U. Mengs,et al.  The carcinogenic action of aristolochic acid in rats , 1982, Archives of Toxicology.

[39]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[40]  J. Marinković,et al.  Diet and Bladder Cancer: A Case–Control Study , 2004, International Urology and Nephrology.

[41]  R. Goldbohm,et al.  Allium vegetable consumption, garlic supplement intake, and female breast carcinoma incidence , 2004, Breast Cancer Research and Treatment.

[42]  T. Shuin,et al.  A phase II study of prophylactic intravesical chemotherapy with 4′-epirubicin in recurrent superficial bladder cancer: comparison of 4′-epirubicin and Adriamycin , 2004, Cancer Chemotherapy and Pharmacology.

[43]  R. Goldbohm,et al.  A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands) , 2004, Cancer Causes & Control.

[44]  G. Thériault,et al.  Mortality and cancer morbidity in a cohort of Canadian petroleum workers , 2003, Occupational and environmental medicine.

[45]  T. Kakizoe.  Chemoprevention of cancer--focusing on clinical trials. , 2003, Japanese journal of clinical oncology.

[46]  R. Keck,et al.  Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. , 2003, The Journal of urology.

[47]  M. Grimm,et al.  Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. , 2003, The Journal of urology.

[48]  R. Hamid,et al.  Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? , 2003, The Journal of urology.

[49]  L. Wheeless,et al.  Grade progression and regression in recurrent urothelial cancer. , 2003, The Journal of urology.

[50]  R. Knuechel,et al.  [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study]. , 2003, Der Urologe. Ausg. A.

[51]  W. Wieland,et al.  Senkung des Rezidivrisikos oberflächlicher Harnblasenkarzinome mittels 5-Aminolävulinsäure-induzierter Fluoreszenzdiagnostik , 2003, Der Urologe, Ausgabe A.

[52]  S. Fukushima,et al.  Urinary bladder lesions induced by persistent chronic low‐dose ionizing radiation , 2003, Cancer science.

[53]  M. Matsushima,et al.  Preventive effects of urinary bladder tumors induced by N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine in rat by green tea leaves , 2003, International journal of urology : official journal of the Japanese Urological Association.

[54]  T. Wheeler,et al.  Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. , 2003, The Journal of urology.

[55]  J. Adolfsson,et al.  Bladder cancer characteristics in a population based study of newly detected tumours , 2003 .

[56]  B. Frei,et al.  Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.

[57]  M. Zeegers,et al.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review , 2003, World Journal of Urology.

[58]  Tom Pickles,et al.  The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  M. Thun,et al.  Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. , 2002, American journal of epidemiology.

[60]  D. Lamm,et al.  Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. , 2002, The Journal of urology.

[61]  D. Albanes,et al.  Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study , 2002, British Journal of Cancer.

[62]  Herbert Stepp,et al.  Role of 5‐aminolevulinic acid in the detection of urothelial premalignant lesions , 2002, Cancer.

[63]  S. Fukushima,et al.  DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine. , 2002, The Journal of urology.

[64]  J. Rassweiler,et al.  Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. , 2002, The Journal of urology.

[65]  G. Mastrangelo,et al.  Epidemiologic evidence of cancer risk in textile industry workers: a review and update , 2002, Toxicology and industrial health.

[66]  J. Pannek.  Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? , 2002, Urology.

[67]  P. Akarasereenont,et al.  The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase. , 2002, Mediators of inflammation.

[68]  A. Böhle.  Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. , 2002, International braz j urol : official journal of the Brazilian Society of Urology.

[69]  B. Ruggeri,et al.  The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  P Schneede,et al.  Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection. , 2001, The Journal of urology.

[71]  S. Cordier,et al.  Fluid consumption and the risk of bladder cancer: Results of a multicenter case‐control study , 2001, International journal of cancer.

[72]  Michael Cookson,et al.  Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. , 2001, The Journal of urology.

[73]  V. Steele,et al.  Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[74]  D. Lamm,et al.  Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies. , 2001, The Journal of nutrition.

[75]  S. Nordling,et al.  Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. , 2001, The American journal of pathology.

[76]  C. Chen,et al.  Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. , 2001, American journal of epidemiology.

[77]  C. la Vecchia,et al.  Epidemiology and prevention of bladder cancer. , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[78]  Debra T. Silverman,et al.  A Meta-Analysis of Bladder Cancer and Diesel Exhaust Exposure , 2001, Epidemiology.

[79]  G. López-Abente,et al.  Tobacco consumption and bladder cancer in non-coffee drinkers , 2001, Journal of epidemiology and community health.

[80]  W. Hong,et al.  Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer , 2000, International journal of cancer.

[81]  E. Rimm,et al.  Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. , 2000, American journal of epidemiology.

[82]  B. Suffoletto,et al.  Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic‐derived S‐allylmercaptocysteine , 2000, The Prostate.

[83]  V. Steele,et al.  Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. , 2000, Cancer research.

[84]  E Dorant,et al.  The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.

[85]  Y. Shyr,et al.  Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. , 2000, The American journal of pathology.

[86]  L. Ryan,et al.  Risk of internal cancers from arsenic in drinking water. , 2000, Environmental health perspectives.

[87]  D A Kessler,et al.  Cancer and herbs. , 2000, The New England journal of medicine.

[88]  T. Shirahama,et al.  Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[89]  D. Knapp,et al.  Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. , 2000, American journal of veterinary research.

[90]  P Vineis,et al.  Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[91]  D. Preston,et al.  Bladder‐cancer incidence in relation to vegetable and fruit consumption: A prospective study of atomic‐bomb survivors , 2000, International journal of cancer.

[92]  A. Smith,et al.  Diet and Bladder Cancer: a Meta-analysis of Six Dietary Variables , 2022 .

[93]  M. Yu,et al.  Non-steroidal anti-inflammatory drugs and bladder cancer prevention , 2000, British Journal of Cancer.

[94]  H. G. van der Poel,et al.  Gender differences in stage distribution of bladder cancer. , 2000, Urology.

[95]  J. Cerhan,et al.  Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. , 2000, American journal of epidemiology.

[96]  A. Andersen,et al.  Cancer incidence and cause specific mortality among workers in two Norwegian aluminum reduction plants. , 2000, American journal of industrial medicine.

[97]  G. Dalbagni,et al.  Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer. , 2000, The Urologic clinics of North America.

[98]  K. Loughlin,et al.  An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy. , 2000, The Urologic clinics of North America.

[99]  T. Sorahan,et al.  A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-β-naphthylamine and o-toluidine , 2000, Occupational and environmental medicine.

[100]  D. Brenner,et al.  Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.

[101]  J. Mellon,et al.  Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer , 2000, BJU international.

[102]  B. Schmitz-Dräger,et al.  Use of Markers in Defining Urothelial Premalignant and Malignant Conditions , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[103]  H. Lei,et al.  The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[104]  H. Herr,et al.  The value of a second transurethral resection in evaluating patients with bladder tumors. , 2000, The Journal of urology.

[105]  P. Russo,et al.  Influence of smoking status on the disease‐related outcomes of patients with tobacco‐associated superficial transitional cell carcinoma of the bladder , 1999, Cancer.

[106]  E. Okajima,et al.  Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. , 1999, Carcinogenesis.

[107]  E. Greiser,et al.  Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[108]  D. Bostwick,et al.  Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. , 1999, Cancer research.

[109]  L. Kiemeney,et al.  Epidemiology of Bladder Cancer , 1999, European Urology.

[110]  C. F. Chen,et al.  Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. , 1999, Carcinogenesis.

[111]  Herbert Stepp,et al.  Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy , 1999, European Urology.

[112]  E. Messing,et al.  Low-dose difluoromethylornithine and polyamine levels in human prostate tissue. , 1999, Journal of the National Cancer Institute.

[113]  Graham M Lord,et al.  Nephropathy caused by Chinese herbs in the UK , 1999, The Lancet.

[114]  Glade Mj.  Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. , 1999 .

[115]  J. Squifflet,et al.  Urothelial lesions in Chinese-herb nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[116]  E. Rimm,et al.  Fluid intake and the risk of bladder cancer in men. , 1999, The New England journal of medicine.

[117]  E. Rimm,et al.  Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. , 1999, Journal of the National Cancer Institute.

[118]  V. Steele,et al.  Preclinical Efficacy Studies of Green and Black Tea Extracts , 1999 .

[119]  E. Solsona,et al.  Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup. , 1999, The Journal of urology.

[120]  V. Steele,et al.  Preclinical efficacy studies of green and black tea extracts. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[121]  C. J. Chen,et al.  Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. , 1999, Cancer research.

[122]  S. Sheweita,et al.  Relationship between Schistosomiasis and Bladder Cancer , 1999, Clinical Microbiology Reviews.

[123]  G. Orth,et al.  Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. , 1999, The Journal of urology.

[124]  D. Theodorescu,et al.  Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression , 1998, International journal of cancer.

[125]  G. Blackburn,et al.  Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. , 1998, Cancer research.

[126]  A. Watson,et al.  Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. , 1998, Histology and histopathology.

[127]  Abelardo Avila-Curiel,et al.  Food, nutrition and the prevention of cancer: a global perspective , 1998 .

[128]  M. Kogevinas,et al.  Cancer risk in the rubber industry: a review of the recent epidemiological evidence. , 1998, Occupational and environmental medicine.

[129]  J. Bushman.  Green tea and cancer in humans: a review of the literature. , 1998, Nutrition and cancer.

[130]  John D. Potter,et al.  Food, nutrition and the prevention of cancer : a global perspective , 2001 .

[131]  T. Inagaki,et al.  The cytotoxic effects of fleroxacin and ciprofloxacin on transitional cell carcinoma in Vitro , 1997, Cancer.

[132]  A. Smith,et al.  Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[133]  F P Perera,et al.  Environment and cancer: who are susceptible? , 1997, Science.

[134]  D. Heisey,et al.  Bladder cancer in renal transplant recipients. , 1997, Urology.

[135]  S. Lippman,et al.  Intermediate end point markers in chemoprevention trials of lung cancer , 1997 .

[136]  R. Bahnson.  Editorial: Squamous Cell Carcinoma of Bladder , 1997 .

[137]  Y. Hsueh,et al.  Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. , 1997, Mutation research.

[138]  P. Nurse.  Regulation of the eukaryotic cell cycle. , 1997, European journal of cancer.

[139]  Y. Hsueh,et al.  Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. , 1997, Mutation research.

[140]  A. Sugawara,et al.  [Chinese herbs nephropathy in the Kansai area: a warning report]. , 1997, Nihon Jinzo Gakkai shi.

[141]  L. Kiemeney,et al.  Familial transitional cell carcinoma among the population of Iceland. , 1997, The Journal of urology.

[142]  A. Nabeeh,et al.  Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study. , 1997, British journal of urology.

[143]  A. Neugut,et al.  Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma , 1997, Cancer.

[144]  S. Cohen,et al.  Epidemiology and etiology of bladder cancer. , 1992, Seminars in surgical oncology.

[145]  J. Gossmann.  Cyclophosphamide-Induced Bladder Cancer , 1997, Annals of Internal Medicine.

[146]  E. Ron,et al.  Cancer patterns in the Middle East--special report from the Middle East Cancer Society. , 1997, Acta oncologica.

[147]  A. Anagnostou,et al.  S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. , 1997, Nutrition and cancer.

[148]  D. Bishop,et al.  A case-control study of diet and prostate cancer. , 1997, British Journal of Cancer.

[149]  J. Manivel,et al.  Cyclophosphamide associated bladder cancer--a highly aggressive disease: analysis of 12 cases. , 1996, The Journal of urology.

[150]  L. Kiemeney,et al.  Familial transitional cell carcinoma. , 1996, The Journal of urology.

[151]  C. Cheney,et al.  Nutrient intake in relation to bladder cancer among middle-aged men and women. , 1996, American journal of epidemiology.

[152]  A. Ristimäki,et al.  Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. , 1996, The Biochemical journal.

[153]  J. M. Peña,et al.  Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[154]  V. Steele,et al.  Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. , 1996, Carcinogenesis.

[155]  G. Curigliano,et al.  Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. , 1996, Carcinogenesis.

[156]  C. van Ypersele de Strihou,et al.  Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. , 1996, Cancer research.

[157]  J. O'fallon,et al.  Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[158]  M. Eichholzer,et al.  Prediction of male cancer mortality by plasma levels of interacting vitamins: 17‐year follow‐up of the prospective Basel study , 1996, International journal of cancer.

[159]  M. Parmar,et al.  The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. , 1996, The Journal of urology.

[160]  R. Goldbohm,et al.  A prospective cohort study on the relationship between onion and leek consumption, garlic supplement use and the risk of colorectal carcinoma in The Netherlands. , 1996, Carcinogenesis.

[161]  T. Seay,et al.  Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. , 1996, The Journal of urology.

[162]  R. Goldbohm,et al.  Consumption of onions and a reduced risk of stomach carcinoma. , 1996, Gastroenterology.

[163]  M. Koraitim,et al.  Changing age incidence and pathological types of schistosoma-associated bladder carcinoma. , 1995, The Journal of urology.

[164]  P. Nieminen,et al.  Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. , 1995, British journal of urology.

[165]  N. Day,et al.  Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: A case—control study , 1995, International journal of cancer.

[166]  S. Groshen,et al.  Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction , 1995, Cancer.

[167]  D. Pode,et al.  Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine. , 1995, Urology.

[168]  S. Wacholder,et al.  Analgesics and cancers of the renal pelvis and ureter , 1995, International journal of cancer.

[169]  S. Johansson,et al.  The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. , 1995, The Journal of urology.

[170]  W. Willett,et al.  Prospective study of toenail selenium levels and cancer among women. , 1995, Journal of the National Cancer Institute.

[171]  Larue,et al.  Human papillomavirus in transitional cell carcinoma of the urinary bladder , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[172]  E. Messing,et al.  Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. , 1995, Urology.

[173]  D. Kwiatkowski,et al.  Potential location of a bladder tumor suppressor gene on chromosome 9q at 9q13 to 9q22.1. , 1995, Urologic oncology.

[174]  K. Helzlsouer,et al.  Oltipraz: Clinical opportunities for cancer chemoprevention , 1995, Journal of cellular biochemistry. Supplement.

[175]  K. Helzlsouer,et al.  Oltipraz: clinical opportunities for cancer chemoprevention. p. , 1995, Journal of cellular biochemistry. Supplement.

[176]  U. Studer,et al.  Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. , 1995, European urology.

[177]  D. Byar,et al.  Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group. , 1995, European urology.

[178]  R Baumgartner,et al.  Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.

[179]  R. Goldbohm,et al.  A prospective cohort study on Allium vegetable consumption, garlic supplement use, and the risk of lung carcinoma in The Netherlands. , 1994, Cancer research.

[180]  O. Rascol,et al.  [Nephropathy associated with Chinese herbal drugs. 2 cases]. , 1994, Presse medicale.

[181]  A. Verhest,et al.  Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. , 1994, Urology.

[182]  P. Nichols,et al.  Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. , 1994, Carcinogenesis.

[183]  H. Scher.  Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. , 1994, The Journal of urology.

[184]  B. Spiegelhalder,et al.  Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. , 1994, Carcinogenesis.

[185]  J. Wiener,et al.  Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. , 1994, The Journal of urology.

[186]  P. But,et al.  Identification of aristolochic acid in Chinese herbs , 1994, The Lancet.

[187]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[188]  J. Dehaven,et al.  Megadose vitamins in bladder cancer: a double-blind clinical trial. , 1994, The Journal of urology.

[189]  W. Stadler.  Molecular events in the initiation and progression of bladder-cancer (review). , 1993, International journal of oncology.

[190]  R. Takahashi,et al.  Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. , 1993, Cancer research.

[191]  A. Komori,et al.  Anticarcinogenic activity of green tea polyphenols. , 1993, Japanese journal of clinical oncology.

[192]  S. Jacobs,et al.  Late invasive recurrence despite long-term surveillance for superficial bladder cancer. , 1993, The Journal of urology.

[193]  J. Freudenheim,et al.  Drinking water, fluid intake, and bladder cancer in western New York. , 1993, Archives of environmental health.

[194]  R Sylvester,et al.  A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. , 1993, The Journal of urology.

[195]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[196]  M. Jadoul,et al.  Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.

[197]  N. Day,et al.  Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis , 1993, International journal of cancer.

[198]  R. Case,et al.  Tumours Of The Urinary Bladder in Workmen Engaged in the Manufacture and Use Of Certain Dyestuff Intermediates In The British Chemical Industry. Part I. The Role Of Aniline, Benzidine, Alpha-Naphthylamine, And Beta-Naphthylamine , 1954, British journal of industrial medicine.

[199]  P. Vineis,et al.  [Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies]. , 1992, La Medicina del lavoro.

[200]  G. Prout,et al.  Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. , 1992, The Journal of urology.

[201]  T. Kuo,et al.  Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. , 1992, British Journal of Cancer.

[202]  B. Henderson,et al.  Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. , 1992, British Journal of Cancer.

[203]  Michael Cookson,et al.  Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. , 1992, The Journal of urology.

[204]  R. Smith,et al.  Acrolein initiates rat urinary bladder carcinogenesis. , 1992, Cancer research.

[205]  D. Cooper,et al.  Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals. , 1992, Carcinogenesis.

[206]  J. Chang-Claude,et al.  Life style and occupational risk factors for bladder cancer in Germany. A case‐control study , 1992, Cancer.

[207]  S. Loening,et al.  13‐cis‐Retinoic acid in chemopreventiion of superficial bladder cancer , 1992 .

[208]  P. Gr,et al.  13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group. , 1992, Journal of cellular biochemistry. Supplement.

[209]  H. Wijkström,et al.  Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. , 1992, The Journal of urology.

[210]  G. Kelloff,et al.  Intermediate endpoint biomarkers for chemoprevention , 1992, Journal of cellular biochemistry. Supplement.

[211]  D. Neal,et al.  Epidermal growth factor receptor and bladder cancer: a review. , 1992, Urologia internationalis.

[212]  K. Helzlsouer,et al.  Mechanisms of chemoprotection by oltipraz , 1992, Journal of cellular biochemistry. Supplement.

[213]  E. Messing,et al.  Epidermal growth factor and its receptor: Markers of— and targets for—chemoprevention of bladder cancer , 1992, Journal of cellular biochemistry. Supplement.

[214]  T. Shinka,et al.  Clinical study on urothelial tumors of dye workers in Wakayama City. , 1991, The Journal of urology.

[215]  E. Riboli,et al.  Diet and bladder cancer in Spain: A multi‐centre case‐control study , 1991, International journal of cancer.

[216]  H. Huland,et al.  Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. , 1991, The Journal of urology.

[217]  J. Hankin,et al.  Dietary factors in cancer of the lower urinary tract , 1991, International journal of cancer.

[218]  S. Barnes,et al.  The role of soy products in reducing risk of cancer. , 1991, Journal of the National Cancer Institute.

[219]  C. J. Chen,et al.  Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. , 1990, Cancer research.

[220]  G. Steineck,et al.  Vitamin A supplements, fried foods, fat and urothelial cancer. A case‐referent study in Stockholm in 1985–87 , 1990, International journal of cancer.

[221]  E. Messing.  Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. , 1990, Cancer research.

[222]  M. Melamed,et al.  Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. , 1990, The Journal of urology.

[223]  H. Lynch,et al.  The Lynch syndrome II and urological malignancies. , 1990, The Journal of urology.

[224]  C. Hogstedt,et al.  Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. , 1990, American journal of industrial medicine.

[225]  P. Nichols,et al.  Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. , 1990, Cancer research.

[226]  H. Tómasson,et al.  The copenhagen case‐control study of renal pelvis and ureter cancer: Role of analgesics , 1989, International journal of cancer.

[227]  J. S. Morris,et al.  Selenium, Lycopene, α-Tocopherol, β-Carotene, Retinol, and Subsequent Bladder Cancer , 1989 .

[228]  A. Miller,et al.  Risk of bladder cancer by source and type of tobacco exposure: A case‐control study , 1989, International journal of cancer.

[229]  R N Hoover,et al.  Occupational risks of bladder cancer in the United States: II Nonwhite men. , 1989, Journal of the National Cancer Institute.

[230]  W. Tseng,et al.  Blackfoot Disease in Taiwan: A 30-Year Follow-up Study , 1989, Angiology.

[231]  B. Spiegelhalder,et al.  Urinary excretion of nitrate, nitrite and N-nitroso compounds in Schistosomiasis and bilharzia bladder cancer patients. , 1989, Carcinogenesis.

[232]  R N Hoover,et al.  Occupational risks of bladder cancer in the United States: I. White men. , 1989, Journal of the National Cancer Institute.

[233]  J. S. Morris,et al.  Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. , 1989, Cancer research.

[234]  G. Cordell,et al.  Evaluation of the mutagenic and cytostatic potential of aristolochic acid (3,4-methylenedioxy-8-methoxy-10-nitrophenanthrene-1-carboxylic acid) and several of its derivatives. , 1988, Mutation research.

[235]  M. Marletta.  Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. , 1988, Chemical Research in Toxicology.

[236]  Chien-Jen Chen,et al.  Atherogenicity and Carcinogenicity of High‐Arsenic Artesian Well Water: Multiple Risk Factors and Related Malignant Neoplasms of Blackfoot Disease , 1988, Arteriosclerosis.

[237]  E. Wynder,et al.  Bladder cancer in relation to cigarette smoking. , 1988, Cancer research.

[238]  D. West,et al.  Fluid intake and bladder cancer in UTAH , 1988, International journal of cancer.

[239]  A. Miller,et al.  Dietary factors and the incidence of cancer of the urinary bladder. , 1988, American journal of epidemiology.

[240]  N. Nissen,et al.  Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. , 1988, The New England journal of medicine.

[241]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[242]  E. Messing,et al.  Normal and malignant human urothelium: in vitro response to blockade of polyamine synthesis and interconversion. , 1988, Cancer research.

[243]  I. Penn,et al.  Secondary neoplasms as a consequence of transplantation and cancer therapy. , 1988, Cancer detection and prevention.

[244]  G. Steineck,et al.  Diet, tobacco and urothelial cancer. A 14-year follow-up of 16,477 subjects. , 1988, Acta oncologica.

[245]  P. O'Brien,et al.  Radical formation during the peroxidase catalyzed metabolism of carcinogens and xenobiotics: the reactivity of these radicals with GSH, DNA, and unsaturated lipid. , 1988, Free radical biology & medicine.

[246]  D. Silverman,et al.  Occupational risks for bladder cancer among men in Sweden. , 1987, Cancer research.

[247]  E. Messing,et al.  Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies. , 1987, The Journal of urology.

[248]  G. Kerr,et al.  Bladder cancer following low or high dose pelvic irradiation. , 1987, Clinical radiology.

[249]  W. Kimberling,et al.  Familial bladder cancer in an oncology clinic. , 1987, Cancer genetics and cytogenetics.

[250]  E. Messing,et al.  Normal and malignant human urothelium: in vitro effects of epidermal growth factor. , 1987, Cancer research.

[251]  I. Thompson,et al.  The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. , 1987, The Journal of urology.

[252]  D. Birt.  Update on the Effects of Vitamins A, C, and E and Selenium on Carcinogenesis 1 , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[253]  L. Kessler,et al.  The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. , 1986, The New England journal of medicine.

[254]  S. Mirvish.  Effects of vitamins C and E on N‐nitroso compound formation, carcinogenesis, and cancer , 1986 .

[255]  R. Frentzel-Beyme,et al.  Life-style and occupational risk factors in cancer of the lower urinary tract. , 1986, American journal of epidemiology.

[256]  S. You,et al.  A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. , 1986, British Journal of Cancer.

[257]  B. Pool,et al.  Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver. , 1986, Carcinogenesis.

[258]  C. J. Chen,et al.  Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. , 1985, Cancer research.

[259]  G. Matanoski,et al.  Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. , 1985, The New England journal of medicine.

[260]  P. Hartge,et al.  Familial and environmental interactions in bladder cancer risk , 1985, International journal of cancer.

[261]  D. Hill,et al.  Incidence of squamous cell carcinoma in patients with long-term catheter drainage. , 1985, The Journal of urology.

[262]  P. Hartge,et al.  Bladder cancer risk and pipes, cigars, and smokeless tobacco , 1985, Cancer.

[263]  A. Wilcox,et al.  CUMULATIVE EFFECTS OF LIFETIME PASSIVE SMOKING ON CANCER RISK , 1985, The Lancet.

[264]  Y. Homma,et al.  Inhibition of carcinogenesis by alpha-difluoromethylornithine in heterotopically transplanted rat urinary bladders. , 1985, Cancer research.

[265]  A. Wilcox,et al.  Passive smoking in adulthood and cancer risk. , 1985, American journal of epidemiology.

[266]  E. Silverberg.  Cancer statistics, 1985 , 1985, CA: a cancer journal for clinicians.

[267]  Morris As.  Advances in the etiology of urothelial cancer. , 1984 .

[268]  P. Hartge,et al.  Urinary tract infection and risk of bladder cancer. , 1984, American journal of epidemiology.

[269]  A. Costello,et al.  Squamous cell carcinoma of bladder. , 1984, Urology.

[270]  A. Morrison.  Advances in the etiology of urothelial cancer. , 1984, The Urologic clinics of North America.

[271]  S. Fukushima,et al.  Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. , 1983, Cancer research.

[272]  R. Bos,et al.  Excretion of mutagens in human urine after passive smoking. , 1983, Cancer letters.

[273]  M. McCredie,et al.  Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. , 1983, British journal of urology.

[274]  M. Habs,et al.  Prevention of urinary bladder tumors in cyclophosphamide‐treated rats by additional medication with the uroprotectors sodium 2‐mercaptoethane sulfonate (mesna) and disodium 2,2′‐dithio‐bis‐ethane sulfonate (dimesna) , 1983, Cancer.

[275]  W Lutzeyer,et al.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.

[276]  M. E. el Alamy,et al.  Association of bacteriuria and urinary nitrosamine formation with Schistosoma haematobium infection in the Qalyub area of Egypt. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[277]  M. H. Hussein,et al.  The impact of schistosomiasis on the pathology of bladder carcinoma , 1981, Cancer.

[278]  D. Schwartz.  Helminths in the induction of cancer II. Schistosoma haematobium and bladder cancer. , 1981, Tropical and geographical medicine.

[279]  R. Edelman,et al.  Single-nutrient effects on immunologic functions. Report of a workshop sponsored by the Department of Food and Nutrition and its nutrition advisory group of the American Medical Association. , 1981, JAMA.

[280]  T. Kakizoe,et al.  Carcinoma of the bladder: a clinical and pathological analysis of 87 autopsy cases. , 1981, The Journal of urology.

[281]  A. Miller,et al.  Tobacco use, occupation, coffee, various nutrients, and bladder cancer. , 1980, Journal of the National Cancer Institute.

[282]  C. Mettlin,et al.  Dietary risk factors in human bladder cancer. , 1979, American journal of epidemiology.

[283]  H. A. Amin.  Squamous cell carcinoma of the bladder. , 1979, The Journal of urology.

[284]  D. Byar,et al.  Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. , 1977, Urology.

[285]  W. Tseng.  Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic , 1977, Environmental health perspectives.

[286]  D. W. Bennett,et al.  Radiation-induced bladder tumors. , 1977, The Journal of urology.

[287]  M. Sporn,et al.  13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat. , 1977, Science.

[288]  A. Althausen,et al.  Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. , 1976, The Journal of urology.

[289]  S. Cohen,et al.  Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide. , 1976, Cancer research.

[290]  A. Morrison,et al.  Epidemiology of bladder cancer. , 1992, Hematology/oncology clinics of North America.

[291]  K. Burnand,et al.  Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. , 1976, British journal of urology.

[292]  J. Schlegel.  PROPOSED USES OF ASCORBIC ACID IN PREVENTION OF BLADDER CARCINOMA * , 1975, Annals of the New York Academy of Sciences.

[293]  D. Lamm,et al.  Familial transitional cell carcinoma of the bladder. , 1975, The Journal of urology.

[294]  H. Awwad,et al.  Clinical staging of malignant lymphoma in patients suspected to have hepato-splenic schistosomiasis. , 1975, The Journal of tropical medicine and hygiene.

[295]  M. Melicow.  Tumors of the bladder: a multifaceted problem. , 1974, The Journal of urology.

[296]  G. Aherne.  Retinoblastoma associated with other primary malignant tumours. , 1974, Transactions of the ophthalmological societies of the United Kingdom.

[297]  A. Chaudhuri,et al.  Letter: Type-A hepatitis. , 1974, Lancet.

[298]  P. Cole,et al.  Occupation and cancer of the lower urinary tract , 1972, Cancer.

[299]  L. Angervall,et al.  Renal pelvic carcinoma in a Swedish district with abuse of a phenacetin-containing drug. , 1969, British journal of urology.

[300]  E. Wynder,et al.  Alpha-naphthylamine and beta-naphthylamine in cigarette smoke. , 1969, Nature.

[301]  Y. Masuda,et al.  α-Naphthylamine and β-Naphthylamine in Cigarette Smoke , 1969, Nature.

[302]  A. LaraRivas,et al.  [ETIOLOGY OF CANCER OF THE BLADDER]. , 1963, Revista mexicana de urologia.

[303]  S. Takahashi,et al.  [Cancer of the renal pelvis]. , 1962, Rinsho geka. Journal of clinical surgery.

[304]  Price Jm,et al.  The metabolism of tryptophan in patients with bladder cancer. , 1960 .

[305]  J. M. Price,et al.  The metabolism of tryptophan in patients with bladder cancer. , 1960, Acta - Unio Internationalis Contra Cancrum.

[306]  S. Wolbach,et al.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN , 1925, The Journal of experimental medicine.

[307]  EINZ,et al.  UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI ) , 2022 .